Krystal Biotech, Inc. KRYS Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s accrued expenses?
- Krystal Biotech, Inc. (KRYS) reported accrued expenses of $3.18M in Q1 2026.
- How has Krystal Biotech, Inc.'s accrued expenses changed year-over-year?
- Krystal Biotech, Inc.'s accrued expenses decreased by 6.3% year-over-year, from $3.39M to $3.18M.
- What is the long-term trend for Krystal Biotech, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s accrued expenses has grown at a 167.8% compound annual growth rate (CAGR), from $26K to $3.58M.